An Inhalable Apoptosis‐Mimicking Functionalized Carbon Dots‐Methylprednisolone Nanomedicine for Synergistic Therapy in Acute Lung Injury
Small · 2026-07 · 22 (41)
DOI: 10.1002/smll.74008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 29.05.2026. Verfasst von Xin Pang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Biorheological Science and Technology of Ministry of Education, Bioengineering College of Chongqing University Chongqing Universit…. Hauptthemen laut MEDLINE: Acute Lung Injury, Carbon Quantum Dots, Apoptosis, Nanomedicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundamental Research Funds for the National Key R&D Project, Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau), JinFeng Laboratory of Chongqing.
Abstract (Originalsprache)
Acute lung injury (ALI) is a life‐threatening inflammatory syndrome closely associated with reactive oxygen species (ROS) burst and dysregulation of M1/M2 macrophage polarization. Therefore, immune regulation of pulmonary macrophages represents a potential strategy to alleviate lung damage. However, existing approaches suffer from imprecise cellular targeting, monofunctional therapeutic effects, and suboptimal biocompatibility. To address these issues, an inhalable, multifunctional biomimetic nanoplatform is proposed that mimics apoptotic bodies (CTM@PS‐Lip). CTM@PS‐Lip is synthesized by fabricating nanoscale liposomes based on the outer leaflet structure of apoptotic cell membranes and encapsulating ROS responsive carbon dots (CDs)‐methylprednisolone (MP) conjugates. Upon inhalation, liposomes rich in phosphatidylserine (PS) can transmit the “eat me” signal, efficiently inducing macrophages to recognize and phagocytose. Subsequently, the high ROS microenvironment in ALI‐affected lung tissues triggers the controlled cargo release for: not only promoting the MP‐mediated immunomodulatory effects by inhibiting M1 macrophage polarization and inducing M2 macrophage polarization but also synergizing with the potent CDs mediated ROS‐scavenging capacity, significantly reducing pulmonary inflammation and promoting tissue repair. Thus, CTM@PS‐Lip integrates imaging, therapy, and biosafety, proving to be a promising strategy for safe and efficient management in ALI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory for Biorheological Science and Technology of Ministry of Education, Bioengineering College of Chongqing University Chongqing University Fuling Hospital, Chongqing University Cancer Hospital., Chongqing, C…
- Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Diseases, Xinqiao Hospital, Army Medical University, Chongqing, China.
- JinFeng Laboratory, Chongqing, China.
ORCID-Profile: Zhiqiang Wang, Xinmei Duan, Wei Wu
Förderung
- Fundamental Research Funds for the National Key R&D Project
- Chongqing Medical Scientific Research Project (Joint Project of Chongqing Health Commission and Science and Technology Bureau)
- JinFeng Laboratory of Chongqing
Zitieren
APA
Pang, X., Deng, Y., Lai, W., He, H., Bao, K., Wu, S., Han, Z., Zhang, W., Wang, Z., Duan, X., & Wu, W. (2026). An Inhalable Apoptosis‐Mimicking Functionalized Carbon Dots‐Methylprednisolone Nanomedicine for Synergistic Therapy in Acute Lung Injury. Small, 22(41). https://doi.org/10.1002/smll.74008
Vancouver
Pang X, Deng Y, Lai W, He H, Bao K, Wu S, et al. An Inhalable Apoptosis‐Mimicking Functionalized Carbon Dots‐Methylprednisolone Nanomedicine for Synergistic Therapy in Acute Lung Injury. Small. 2026;22(41). doi:10.1002/smll.74008
BibTeX
@article{Pang2026,
author = {Pang, Xin and Deng, Yikun and Lai, Weiju and He, Houhua and Bao, Kaiwen and Wu, Shuai and Han, Zhiqiang and Zhang, Wen and Wang, Zhiqiang and Duan, Xinmei and Wu, Wei},
title = {An Inhalable Apoptosis‐Mimicking Functionalized Carbon Dots‐Methylprednisolone Nanomedicine for Synergistic Therapy in Acute Lung Injury},
journal = {Small},
year = {2026},
volume = {22},
number = {41},
doi = {10.1002/smll.74008}
}
EUVIMED